155 related articles for article (PubMed ID: 24498150)
1. Unraveling the hidden heterogeneities of breast cancer based on functional miRNA cluster.
Li L; Liu C; Wang F; Miao W; Zhang J; Kang Z; Chen Y; Peng L
PLoS One; 2014; 9(1):e87601. PubMed ID: 24498150
[TBL] [Abstract][Full Text] [Related]
2. Unravelling the hidden heterogeneities of diffuse large B-cell lymphoma based on coupled two-way clustering.
Zhang W; Li L; Li X; Jiang W; Huo J; Wang Y; Lin M; Rao S
BMC Genomics; 2007 Sep; 8():332. PubMed ID: 17888167
[TBL] [Abstract][Full Text] [Related]
3. Dissecting cancer heterogeneity based on dimension reduction of transcriptomic profiles using extreme learning machines.
Wang K; Duan X; Gao F; Wang W; Liu L; Wang X
PLoS One; 2018; 13(9):e0203824. PubMed ID: 30216380
[TBL] [Abstract][Full Text] [Related]
4. BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome.
Madden SF; Clarke C; Gaule P; Aherne ST; O'Donovan N; Clynes M; Crown J; Gallagher WM
Breast Cancer Res; 2013; 15(4):R52. PubMed ID: 23820017
[TBL] [Abstract][Full Text] [Related]
5. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
7. Pathway-based analysis of the hidden genetic heterogeneities in cancers.
Zhao X; Zhong S; Zuo X; Lin M; Qin J; Luan Y; Zhang N; Liang Y; Rao S
Genomics Proteomics Bioinformatics; 2014 Feb; 12(1):31-8. PubMed ID: 24462714
[TBL] [Abstract][Full Text] [Related]
8. Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
Sherafatian M
Gene; 2018 Nov; 677():111-118. PubMed ID: 30055304
[TBL] [Abstract][Full Text] [Related]
9. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
10. Peeling off the hidden genetic heterogeneities of cancers based on disease-relevant functional modules.
Xu JZ; Guo Z; Zhang M; Li X; Li YJ; Rao SQ
Mol Med; 2006; 12(1-3):25-33. PubMed ID: 16838067
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
12. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
13. Clustering analysis of microRNA and mRNA expression data from TCGA using maximum edge-weighted matching algorithms.
Ding L; Feng Z; Bai Y
BMC Med Genomics; 2019 Aug; 12(1):117. PubMed ID: 31382962
[TBL] [Abstract][Full Text] [Related]
14. A microRNA signature associated with early recurrence in breast cancer.
Pérez-Rivas LG; Jerez JM; Carmona R; de Luque V; Vicioso L; Claros MG; Viguera E; Pajares B; Sánchez A; Ribelles N; Alba E; Lozano J
PLoS One; 2014; 9(3):e91884. PubMed ID: 24632820
[TBL] [Abstract][Full Text] [Related]
15. Refinement of breast cancer molecular classification by miRNA expression profiles.
Søkilde R; Persson H; Ehinger A; Pirona AC; Fernö M; Hegardt C; Larsson C; Loman N; Malmberg M; Rydén L; Saal L; Borg Å; Vallon-Christerson J; Rovira C
BMC Genomics; 2019 Jun; 20(1):503. PubMed ID: 31208318
[TBL] [Abstract][Full Text] [Related]
16. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
[TBL] [Abstract][Full Text] [Related]
18. Expression of micrornas in molecular genetic breast cancer subtypes.
Kolesnikov NN; Veryaskina YA; Titov SE; Rodionov VV; Gening TP; Abakumova TV; Kometova VV; Torosyan MK; Zhimulev IF
Cancer Treat Res Commun; 2019; 20():100026. PubMed ID: 31255253
[TBL] [Abstract][Full Text] [Related]
19. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE
Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807
[TBL] [Abstract][Full Text] [Related]
20. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
